Longevity & AgingKidney organoids reveal how fibrosis forms and tubules regenerate after hypoxia and inflammation
Kidney fibrosis drives chronic kidney disease, yet no approved therapy stops it, partly because animal and tissue models poorly capture human biology. Researchers grew kidney organoids from human induced pluripotent stem cells and injured them with low oxygen (1% for 48 hours), the inflammatory cytokine IL-1β, or both, to mimic ischemia-reperfusion injury. Only the combination produced strong fibrosis, with higher fibronectin and collagen type I and loss of tubular and glomerular markers. Over two weeks, fibronectin returned to control levels and collagen I stayed elevated. Tubular markers recovered alongside rising CD133+ and CD24+ progenitor-like cells and proliferation, while podocyte-containing glomerular structures barely recovered. The model could help test anti-fibrotic and pro-regenerative drugs.